Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
0.9383
+0.0383 (4.26%)
Apr 23, 2026, 4:00 PM EDT - Market closed

SHPH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
7.864.082.381.30.72
Research & Development
4.053.623.521.051.02
Total Operating Expenses
11.927.75.892.341.74
Operating Income
-11.92-7.7-5.89-2.34-1.74
Interest Income
00.040.08--
Interest Expense
-0.07-1.21-2.49-0.48-0.05
Other Non-Operating Income (Expense)
0.26-0.281.71-2.170.64
Total Non-Operating Income (Expense)
0.2-1.45-0.7-2.650.59
Pretax Income
-11.72-9.14-6.59-5-1.15
Net Income
-11.72-9.14-6.59-6.75-1.26
Net Income Attributable to Preferred Dividends
---1.750.1
Net Income to Common
-11.72-9.14-6.59-6.75-1.26
Shares Outstanding (Basic)
20000
Shares Outstanding (Diluted)
20000
Shares Change (YoY)
1318.21%54.71%60.51%-0.11%
EPS (Basic)
-7.16-79.65-88.25-126.00-24.00
EPS (Diluted)
-7.16-82.60-88.25-126.00-24.00
Shares Outstanding
2.020.160.070.07-
Free Cash Flow
-9.48-7.33-5.6-2.67-0.3
Free Cash Flow Per Share
-5.79-63.44-75.02-57.33-6.46
EBITDA
-11.63-7.69-5.89-2.34-1.68
EBIT
-11.92-7.7-5.89-2.34-1.74
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q